Bryan R. Haugen
Affiliations: | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Oncology, Molecular BiologyGoogle:
"Bryan Haugen"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bischoff LA, Ganly I, Fugazzola L, et al. (2024) Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update. Jama Otolaryngology-- Head & Neck Surgery |
Greca A, Grau L, Arbet J, et al. (2023) Anthropometric, dietary, and lifestyle factors and risk of advanced thyroid cancer: The NIH-AARP diet and health cohort study. Clinical Endocrinology |
Pozdeyev N, Dighe M, Barrio M, et al. (2023) Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant. The Journal of Clinical Endocrinology and Metabolism |
Jeon MJ, Haugen BR. (2022) Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models. Endocrinology and Metabolism (Seoul, Korea). 37: 830-838 |
Mehta V, Naraparaju A, Liao D, et al. (2021) What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision. Thyroid : Official Journal of the American Thyroid Association |
Figge JJ, Gooding WE, Steward DL, et al. (2021) Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology? Thyroid : Official Journal of the American Thyroid Association |
Thor AD, Wahdan-Alaswad RS, Edgerton SM, et al. (2020) Exogenous Thyroid Hormone is Associated with Shortened Survival and Upregulation of High Risk Gene Expression Profiles in Steroid Receptor Positive Breast Cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Sawka AM, Alexander EK, Bianco AC, et al. (2020) Challenges in Developing Recommendations based on Low Quality Evidence in Thyroid Guidelines. Thyroid : Official Journal of the American Thyroid Association |
Pozdeyev N, Erickson T, Zhang L, et al. (2020) Comprehensive Immune Profiling of Medullary Thyroid Cancer. Thyroid : Official Journal of the American Thyroid Association |
Haugen B, French J, Worden FP, et al. (2020) Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC): Results of a multicenter phase II international thyroid oncology group trial. Journal of Clinical Oncology. 38: 6512-6512 |